AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Home-based Gait and Balance Training in Patients With Movement Disorders

RecruitingNAAges 18 Years - 75 YearsAllForschungszentrum Juelich
💬

In plain words

What the trial is, and whether it could suit you

The research project is an experimental study with three study visits at the study site at the University Hospital Düsseldorf (UKD) / Heinrich Heine University Düsseldorf (HHU) and a three-week training phase in a parallel design. Patients with movement disorders (ataxia or Parkinson\'s disease) can take part. The training phase includes individually adapted, targeted, video-based coordination and balance training, which should lead to an improvement in gait and balance. Two different training protocols are carried out in parallel for three weeks each: One with 20 minutes of training per day, four days per week; and one with a training duration of 40 minutes per day, only two days per week. All patients initially take part in a one-week familiarization phase without training and are then randomly assigned to one of the two training protocols or the control group without additiona

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * clinical diagnosis of cerebellar ataxia or idiopathic Parkinson's syndrome * opportunity to walk a distance of four meters unhindered at home Exclusion Criteria: * other diseases with an impact on motor skills * severe primary psychiatric illnesses * current drug or alcohol addiction * consumptive diseases * poor general condition * increased risk of falling (anamnestic fall frequency of ≥ 1x per week or as assessed by the attending physician) * incapacitated patients in official or court custody or patients unable to give consent * for PD patients taking medication: not being able to carry out the measurement in the on-phase of the medication
💊

What it tests

  • Gait and balance training
📍

Where

1 site
Universitätsklinikum Düsseldorf, Institut für Klinische Neurowissenschaften und Medizinische Psychologie
Düsseldorf, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy